SWITZERLAND – The FDA approved Swiss biotech Idorsia’s first drug, known commercially as Quviviq, for the treatment of adults suffering from insomnia. The medication belongs to a new class of…
Read MoreSWITZERLAND – The FDA approved Swiss biotech Idorsia’s first drug, known commercially as Quviviq, for the treatment of adults suffering from insomnia. The medication belongs to a new class of…
Read More